Ax3.Bio is a pre-clinical stage medical device company focused on engineering and commercializing smart, active, and bioresorbable medical implants. Their mission is to accelerate healing and improve patient outcomes through their core innovation, the Ax3™ platform. This technology, originating from research at Oregon State University, aims to provide programmable drug release and on-demand therapeutic activation to address complications like infections and inflammation associated with traditional implants.

Founded in

United States